|Articles|April 1, 2020
- BioPharm International-04-01-2020
- Volume 33
- Issue 4
BioPharm International, April 2020 Issue (PDF)
Click the title above to open the BioPharm International April 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 6 years ago
Bioreactors Redefine Upstream Productivityalmost 6 years ago
Critical Knowledge for Preparing Auditsalmost 6 years ago
Can Vaccine Development Be Safely Accelerated?almost 6 years ago
Lower Taxes, More Flexibility Crucial to Retaining Pharma Employmentalmost 6 years ago
What’s New in Downstream Technologiesalmost 6 years ago
Benchtop Centrifugesalmost 6 years ago
Chromatography Columnsalmost 6 years ago
Ensuring Smooth Tech Transfer of Bioprocess Operationsalmost 6 years ago
Biosimilars Tackle Interchangeability Standardsalmost 6 years ago
Contamination Control for Cell TherapyNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How FDA’s Bayesian Guidance Could Accelerate Adaptive Trial Design in Biopharmaceuticals
2
Agenus Closes $141 Million Immunotherapy Collaboration with Zydus Lifesciences
3
Why Biotech’s Clinical Maturity Is Driving New Partnerships and Capacity Plays
4
Johnson & Johnson Announces Second $2 Billion Manufacturing Facility in North Carolina
5
